Marianne Bjordal PhD, MBA

General Partner

Marianne joined 3B Future Health Fund in 2018 and was promoted to Partner in 2022. She has more than 15 years experience in research and early stage investment. Prior to joining 3B Future Health, Marianne worked as a researcher for the French National Centre for Scientific Research (CNRS). She is a former Marie Curie Early-Stage Researcher and was awarded the AXA Prize from the French Academy of Science in 2014.

Marianne received an M.Sc. in Molecular Biology from the University of Bergen in Norway, a Ph.D. in Molecular and Cellular Biology from the University of Nice in France and an MBA from the IAE Nice Graduate School of Management, France.

She is a former board member of Gain Therapeutics Inc [GANX] and currently serves on the board of NeoPhore Ltd, Epsilogen Ltd, Sibylla Biotech S.p.A. and GenEp Inc.

Our Team

Get in touch

Thank you for your form submission, we will get in contact with you shortly.